How severe is CVE-2023-33364?

CVE-2023-33364 has a CVSS 3.x base score of 8.8, rated high severity. It is exploitable over network with low attack complexity, requires low privileges and no user interaction. Impact on confidentiality is high, integrity high, and availability high.

Is CVE-2023-33364 being actively exploited?

It is not currently listed in CISA's KEV catalog. Its EPSS exploit-prediction score is 2% (73rd percentile), an estimate of the probability of exploitation in the next 30 days.

What products are affected by CVE-2023-33364?

CVE-2023-33364 affects Supremainc Biostar 2. See the affected-products list for the exact vulnerable versions.

How do I fix CVE-2023-33364?

Review the linked vendor and NVD advisories for patched versions and mitigations, then upgrade or apply the recommended workaround. Given its high severity, prioritise patching exposed systems.

When was CVE-2023-33364 published?

CVE-2023-33364 was published on 2023-08-03 and last updated on 2026-06-17.

CVE-2023-33364

CVE-2023-33364 is a high-severity vulnerability in Supremainc Biostar 2 with a CVSS 3.x base score of 8.8. It is not currently listed as actively exploited by CISA, and its EPSS exploit-prediction score is low. The underlying weakness is classified as CWE-78.

Key facts

Severity: High (CVSS 3.x base score 8.8)
EPSS exploit prediction: 2% (73rd percentile)
Actively exploited: Not listed in CISA KEV
Weakness: CWE-78
Affected product: Supremainc Biostar 2
Published: 2023-08-03
Last modified: 2026-06-17

Description

An OS Command injection vulnerability exists in Suprema BioStar 2 before V2.9.1, which allows authenticated users to execute arbitrary OS commands on the BioStar 2 server.

Frequently asked questions

What is CVE-2023-33364?: An OS Command injection vulnerability exists in Suprema BioStar 2 before V2.9.1, which allows authenticated users to execute arbitrary OS commands on the BioStar 2 server.
How severe is CVE-2023-33364?: CVE-2023-33364 has a CVSS 3.x base score of 8.8, rated high severity. It is exploitable over network with low attack complexity, requires low privileges and no user interaction. Impact on confidentiality is high, integrity high, and availability high.
Is CVE-2023-33364 being actively exploited?: It is not currently listed in CISA's KEV catalog. Its EPSS exploit-prediction score is 2% (73rd percentile), an estimate of the probability of exploitation in the next 30 days.
What products are affected by CVE-2023-33364?: CVE-2023-33364 affects Supremainc Biostar 2. See the affected-products list for the exact vulnerable versions.
How do I fix CVE-2023-33364?: Review the linked vendor and NVD advisories for patched versions and mitigations, then upgrade or apply the recommended workaround. Given its high severity, prioritise patching exposed systems.
When was CVE-2023-33364 published?: CVE-2023-33364 was published on 2023-08-03 and last updated on 2026-06-17.

References

Affected products (1)

cpe:2.3:a:supremainc:biostar_2:*:*:*:*:*:*:*:*

More vulnerabilities in Supremainc Biostar 2

CVE-2023-33366 — High (CVSS 8.8): A SQL injection vulnerability exists in Suprema BioStar 2 before 2.9.1, which allows authenticated users to inject…
CVE-2023-31923 — High (CVSS 8.8): Suprema BioStar 2 before 2022 Q4, v2.9.1 has Insecure Permissions. A vulnerability in the web application allows an…
CVE-2022-38351 — High (CVSS 8.8): A vulnerability in Suprema BioStar (aka Bio Star) 2 v2.8.16 allows attackers to escalate privileges to System…
CVE-2023-33365 — High (CVSS 7.5): A path traversal vulnerability exists in Suprema BioStar 2 before 2.9.1, which allows unauthenticated attackers to…
CVE-2023-33363 — High (CVSS 7.5): An authentication bypass vulnerability exists in Suprema BioStar 2 before 2.9.1, which allows unauthenticated users to…
CVE-2020-15050 — High (CVSS 7.5): An issue was discovered in the Video Extension in Suprema BioStar 2 before 2.8.2. Remote attackers can read arbitrary…

All CVEs affecting Supremainc Biostar 2 →

Other CWE-78 (OS Command Injection) vulnerabilities

CVE-2026-19188 — Critical (CVSS 10.0): A critical OS command injection vulnerability has been identified in the Haiwell IoT Cloud HMI Gateway product. The…
CVE-2026-48362 — Critical (CVSS 10.0): ColdFusion is affected by an Improper Neutralization of Special Elements used in an OS Command ('OS Command Injection')…
CVE-2026-16812 — Critical (CVSS 10.0): VeloCloud Orchestrator (VCO) on-prem has a security issue where this issue may allow a remote attacker to access…
CVE-2026-6516 — Critical (CVSS 10.0): Zohocorp ManageEngine ADAudit Plus versions before 8606 are affected by Unauthenticated Remote code execution due to…
CVE-2026-46339 — Critical (CVSS 10.0): 9Router is an AI router & token saver. From 0.4.30 until 0.4.37, 9Router's src/proxy.js middleware did not protect…
CVE-2026-59726 — Critical (CVSS 10.0): Ruflo is an agent meta-harness for Claude Code and Codex. Prior to 3.16.3, ruflo's default docker-compose deployment…

Browse all CWE-78 (OS Command Injection) vulnerabilities →